BioXcel Therapeutics, Inc. (BTAI) NASDAQ
1.20
-0.03(-2.44%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.20
-0.03(-2.44%)
Currency In USD
| Market Cap | 19.53M |
| Enterprise Value | 100.71M |
| P/E Ratio | -0.21 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 50.61 |
| Price/Book Ratio | -0.15 |
| Enterprise/Revenue | 177.05 |
| Enterprise/EBITDA | -2.08 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -108.87 |
| Operating Margin | -77.97 |
| Return On Assets | -1.56 |
| Return On Equity | 0.73 |
| Revenue | 642,000 |
| Revenue/Share | 0.05 |
| Gross Profit | 178,000 |
| EBITDA | -49.41M |
| Net Income | -69.9M |
| Diluted EPS | -5.73 |
| Total Cash | 28.42M |
| Total Cash/Share | 2.33 |
| Total Debt | 109.59M |
| Total Debt/Equity | -1.15 |
| Current Ratio | 0.83 |
| Book Value Per Share | -7.82 |
| 52-Week Change | -29.82 |
| 52-Week High | 8.08 |
| 52-Week Low | 1.01 |
| Moving Average 50 Days | 1.36 |
| Moving Average 200 Days | 2.19 |
| Average Volume | 1.57M |
| Shares Outstanding | 27.07M |
| % Held by Institutions | 24.91 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:16 |
| Last Split Date | February 10, 2025 |